Non-tuberculous Mycobacterial Infections
📧 Sign up to get email alerts when something new happens for Non-tuberculous Mycobacterial Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial [Phase 2]
This clinical trial update outlines the Phase 2 FORMaT adaptive platform trial evaluating a novel combination treatment (Arm D) versus stand…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Lamprene Multiple Patient Program
A clinical trial update for a Lamprene (clofazimine) multiple patient program sponsored by Novartis Pharmaceuticals for non-tuberculous myco…
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Treatment Monitoring for NTM Infections With a Symptom Diary
This clinical trial update describes a study on monitoring treatment for Non-Tuberculous Mycobacterial infections using a symptom diary; the…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Linezolid for Treatment of Nontuberculous Mycobacterial Diseases [Phase 4]
Clinical trial update on a Phase 4 study evaluating linezolid for non-tuberculous mycobacterial infections. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma [Phase 2]
Phase 2 trial evaluating interferon gamma for non-tuberculous mycobacterial infections has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.